Skip to Main Content
Contribute Try STAT+ Today

As the CEO of Pfizer, the world’s largest drug maker, Ian Read followed a years-long pricing strategy that reaped billions for his company. It was like clockwork: jack up prices every six months. The moves did not go entirely unnoticed, but Pfizer generally escaped much flak because other pharma companies did the same thing.

But Read’s pricing game plan didn’t seem so shrewd when President Trump entered the picture last week. Days earlier, Pfizer was virtually alone in raising prices for dozens of drugs — many by more than 9 percent — and it prompted a raging tweet from Trump. In a brief phone call with the president that Read sought on Tuesday night to defuse the uproar, the CEO backed down and deferred the hikes.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Truly good corporate governance includes practices that align the interests of the chief executive not with shareholders but with employees, customers, and society as a whole. The “shareholder value above all” mantra is responsible for much of the pathology of business today. Just saying.

Comments are closed.